Meilleur Technologies
About Meilleur Technologies
Meilleur Technologies is a company founded in 2018 was acquired by Lantheus in July 2024. Meilleur Technologies offers products and services including NAV-4694 and Imaging Tools. Meilleur Technologies operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Meilleur Technologies Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Meilleur Technologies
Meilleur Technologies offers a comprehensive portfolio of products and services, including NAV-4694 and Imaging Tools.
Beta-amyloid imaging biomarker for Alzheimer's detection in clinical trials.
Provides informatics and tools for neurological research and diagnostics.
Funding Insights of Meilleur Technologies
Detailed funding history for Meilleur Technologies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Meilleur Technologies
Meilleur Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Lantheus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of diagnostic imaging agents and targeted therapeutics
|
Locked | Locked | Locked |
Investor details for Meilleur Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Meilleur Technologies
Investment portfolio details for Meilleur Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Meilleur Technologies
Detailed financials for Meilleur Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Meilleur Technologies Comparisons
Peer comparison for Meilleur Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Meilleur Technologies
Meilleur Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services for small molecules are provided.
|
|
| Locked | Locked | Locked |
CDMO services for pharma, biotech, and specialty ingredients are provided.
|
|
| Locked | Locked | Locked |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| Locked | Locked | Locked |
Generic drugs and clinical research services are provided globally.
|
|
| Locked | Locked | Locked |
Laboratory testing, clinical trial research, and biopharma services are provided.
|
|
| Locked | Locked | Locked |
AI powered scientific data management and workflow automation solutions
|
Detailed competitors of Meilleur Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Meilleur Technologies
Complete news archive for Meilleur Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Meilleur Technologies
Meilleur Technologies was founded in 2018.
Meilleur Technologies provider of biomarkers and therapeutics development services through providing healthcare solutions, biopharma outsourcing, diversified, and small molecules peptides. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Meilleur Technologies offers NAV-4694 and Imaging Tools.
Meilleur Technologies has 1 investor. Key investors include Lantheus.